Your session is about to expire
← Back to Search
Eplerenone 50mg for High Blood Pressure (ENOVA Trial)
ENOVA Trial Summary
This trial will enroll participants with mild stage 1 hypertension to see if a certain kind of protein in their urine can predict if they will respond to a specific kind of blood pressure medication.
ENOVA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowENOVA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 2 trial • 17 Patients • NCT01822561ENOVA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the administration of Eplerenone 50mg sanctioned by the FDA?
"The safety of taking Eplerenone 50mg was rated a 3 as it is in Phase 4, signifying that the drug has already been approved."
To whom is this experimental research open?
"This clinical trial seeks 30 individuals aged 21 to 65 who have hypertension. Applicants must demonstrate a Systolic Blood Pressure (SBP) of 140 mmHg or higher, and Diastolic Blood Pressure (DBP) of 90 mmHg or higher on two occasions, as well as having been taking 1-2 antihypertensive medications for at least 6 weeks."
Could you provide an overview of the illnesses typically treated with Eplerenone 50mg?
"Eplerenone 50mg is a viable treatment option for individuals with LVF lower than 40%, congestive heart failure, hypertensive disease, and hypesthesia."
Are geriatric patients eligible for participation in this experiment?
"This study's inclusion criteria necessitates potential trial goers between the ages of 21 and 65. Apart from this research, there are 56 trials aimed at younger patients and 674 studies targeted towards seniors."
Are there any vacant positions still available for participants in this clinical investigation?
"This particular clinical trial is no longer recruiting. It was initially posted on October 1st 2022 and most recently edited on September 16th of the same year. However, there are 746 trials actively looking for participants with hypertension as well as 13 different studies searching for those taking eplerenone 50mg medication."
How many test subjects have been accepted into this clinical research?
"Unfortunately, this trial is no longer accepting participants. It was initially listed on October 1st 2022 and most recently updated September 16th 2022. To help with your search for clinical trials, there are currently 746 studies actively looking for people with hypertension and 13 more seeking patients to take Eplerenone 50mg."
Share this study with friends
Copy Link
Messenger